s'authentifier
version française rss feed
HAL : halsde-00660907, version 1

Fiche détaillée  Récupérer au format
Comptes Rendus Chimie (2011) ss presse
Activity of trioxaquine PA1259 in mice infected by Schistosoma mansoni = Activité de la trioxaquine PA1259 chez la souris infectée par Schistosoma mansoni
Jérôme Boissier1, Julien Portela1, V. Pradines, F. Coslédan, A. Robert2, B. Meunier3
(17/12/2011)

Schistosomiasis is a chronic life-threatening parasitic disease concerning more than 200 million people in the World. Little attention has been paid to schistosomiasis over the last 30 years, and praziquantel is the only drug in use to control this disease. In the absence of a vaccine, there is a real need for new drugs in order both to improve the efficacy of the treatment and to delay the development of praziquantel resistant schistosomes. The present note reports the significant reduction of the worm burden after oral administration of trioxaquine PA1259 to mice infected by Schistosoma mansoni .
1 :  PFE - Parasitologie fonctionnelle et évolutive
2 :  LPNHE - Laboratoire de Physique Nucléaire et de Hautes Énergies
3 :  IBCP - Institut de biologie et chimie des protéines [Lyon]
Sciences de l'environnement/Biodiversité et Ecologie
Drug design – Heme proteins – Iron – Medicinal chemistry – Redox chemistry – Schistosomiasis – Trioxanes